Efficacy of sinus crestal elevation with demineralized dentin matrix at the apex of the implants
Abstract
This study evaluated the clinical and radiographic outcomes of using demineralized dentin matrix (DDM) as a graft material at the implant apex during crestal sinus floor elevation. We hypothesized that DDM would promote predictable bone regeneration at the sinus floor and facilitate implant stability with minimal surgical morbidity. A retrospective analysis was performed on 55 implants placed with transcrestal sinus floor elevation and DDM grafting at the implant apex in the posterior maxilla. Radiographic outcomes were assessed with CBCT. The primary variable was vertical bone gain at the former sinus floor. Secondary outcomes included the proportion of implant protrusion length replaced by new bone (bone gain), implant survival, and sinus health. Pearson correlation and t-tests were used to analyze relationships between implant protrusion length, sinus width, and bone gain. All 55 implants remained functional and osseointegrated after a mean follow-up of 48.1 ± 32.7 months, yielding a 100% survival rate. The mean implant protrusion into the sinus was 3.42 ± 1.27 mm, and mean bone gain at the sinus floor was 1.97 ± 1.18 mm. On average, 61.5% of the protruded implant length was covered by new bone. Implants protruding ≥ 4 mm showed significantly greater absolute bone gain than those < 4 mm (2.50 vs. 1.65 mm, p = 0.04), although the bone fill percentage was similar between groups. Implants in narrower sinuses exhibited higher bone fill (77.8% vs. 46.8%, p < 0.01) and greater…
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.